Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BradsaudeBSP:SAUD3 +0.36%94 Equity-to-Asset is 0.45 as of Jun. 2026, which is 27% below its 10-year median of 0.62. GuruFocus rates BSP:SAUD3 with a GF Score™ of 94/100 and a GF Value™ of R$18.28 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 18 Healthcare Plans companies, Bradsaude ranks better than 55.56% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Bradsaude's Total Stockholders Equity for the quarter that ended in Jun. 2026 was R$18,706 Mil. Bradsaude's Total Assets for the quarter that ended in Jun. 2026 was R$41,712 Mil.
Therefore, Bradsaude's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.45.
The historical rank and industry rank for Bradsaude's Equity-to-Asset or its related term are showing as below:
BSP:SAUD3'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.45 Med: 0.62 Max: 0.71
Current: 0.45
During the past 13 years, the highest Equity to Asset Ratio of Bradsaude was 0.71. The lowest was 0.45. And the median was 0.62.
BSP:SAUD3's Equity-to-Asset is ranked better than 55.56% of 18
companies
in the Healthcare Plans industry
Industry Median: 0.35
vs BSP:SAUD3: 0.45
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Bradsaude Equity-to-Asset Related Terms
Bradsaude Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Bradsaude's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:SAUD3 vs UNH, CVS, ELV: Equity-to-Asset Comparison
For the Healthcare Plans subindustry, Bradsaude's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bradsaude Equity-to-Asset vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Bradsaude's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Bradsaude's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Bradsaude's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bradsaude (BSP:SAUD3) has a Equity-to-Asset of 0.45 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Bradsaude and its competitors. This is 27% below median its historical median of 0.62. Over the past decade, Bradsaude's Equity-to-Asset has ranged from 0.45 to 0.71. According to the industry distribution chart, Bradsaude ranks #8 out of 18 companies in the Healthcare Plans industry, placing it in the top 44.4%.
Is Bradsaude's Equity-to-Asset too high?
Bradsaude's current Equity-to-Asset of 0.45 is 27% below median its 10-year median of 0.62. Over the past 10 years, this metric has ranged from a low of 0.45 to a high of 0.71. The Healthcare Plans industry median Equity-to-Asset is 0.35. Bradsaude's value of 0.45 is 28.6% above this industry median. Based on the distribution chart, Bradsaude ranks #8 out of 18 companies in the Healthcare Plans industry, which is above the industry midpoint. Overall, Bradsaude has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bradsaude's Equity-to-Asset compare to UNH and CVS?
According to the Healthcare Plans industry distribution chart, Bradsaude ranks #8 out of 18 companies for Equity-to-Asset. This puts Bradsaude in the upper half of its industry. The industry median Equity-to-Asset is 0.35. Bradsaude's value of 0.45 is 28.6% above this benchmark. Historically, Bradsaude's own Equity-to-Asset has ranged from 0.45 to 0.71 over the past decade. While the company's 10-year median is 0.62 vs. the industry median of 0.35, Bradsaude has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Plans company?
The median Equity-to-Asset among Healthcare Plans companies is 0.35, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bradsaude's current Equity-to-Asset of 0.45 is 28.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Bradsaude and its competitors. For the Healthcare Plans industry, the median Equity-to-Asset is 0.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bradsaude's current Equity-to-Asset is 0.45, which is 27% below median its own 10-year median of 0.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bradsaude stock overvalued right now?
Based on GuruFocus' analysis, Bradsaude (BSP:SAUD3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$18.28, compared to a current price of R$13.77 — trading 24.7% below its estimated fair value. The current Equity-to-Asset is 0.45, which is 27% below median its 10-year median of 0.62 and 28.6% above the Healthcare Plans industry median of 0.35. Bradsaude's overall GF Score™ is 94/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Bradsaude (BSP:SAUD3), the current Equity-to-Asset is 0.45 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bradsaude (BSP:SAUD3) Overvalued in 2026?
Based on GuruFocus' analysis, Bradsaude stock appears to be undervalued.
The current stock price of R$13.77 is trading 24.7% below its estimated GF Value™ of R$18.28.
GuruFocus considers Bradsaude to be Modestly Undervalued.
Key valuation signals for BSP:SAUD3:
Equity-to-Asset: 0.45 (27% below median its 10-year median of 0.62)
GF Value™: R$18.28 vs. price of R$13.77 (24.7% below fair value)
Industry Position: 28.6% above the Healthcare Plans median (#8 of 18)
No single metric tells the full story. See the BSP:SAUD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bradsaude SA operates a healthcare ecosystem in Brazil formed through the consolidation of companies across different healthcare segments. Its operations include health and dental insurance, hospitals, primary care clinics, healthcare technology, diagnostics, and oncology services. The company serves more than 13 million beneficiaries and operates a healthcare network that includes approximately 4,000 hospital beds across the country.
94GF Score
Get the complete analysis for BSP:SAUD3
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:SAUD3 has been successfully added to your 
